TRANSLATION OF DISULFIRAM AS NOVEL ANTICANCER THERAPY
ZNDDC, A NOVEL CELMOD-LIKE AGENT BINDS TO DDB1-CRBN COMPLEX, DEMONSTRATES SYNERGISM WITH BTZ AND IMIDS AND OVERCOMES IMIDS RESISTANCE IN MYELOMA CELL LINES AND PRIMARY SAMPLES
TRANSLATIONAL DEVELOPMENT OF PLGA-ENCAPSULATED DISULFIRAM MICROPARTICLES FOR TREATMENT OF MALIGNANT MESOTHELIOMA
PLGA-ENCAPSULATED DISULFIRAM TARGETS GLIOBLASTOMA STEM CELLS IN VITRO AND IN VIVO BY MODULATION OF HYPOXIA-NF-κB PATHWAY
